Julie A Letsinger, MD
Dermatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Letsinger’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A74577 · Current
Licensed to practise in California · since 2001 · expires 2027-03-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$151,805
Medicare paid this office $151,805 for 406 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 253 | $46,197 | $112 |
| Short return visit (20+ min) | 242 | $27,266 | $80 |
| Destruction of precancer skin growth, 1 growth | 247 | $21,175 | $53 |
| Destruction of skin growth, 1-14 growths | 93 | $14,946 | $113 |
| Biopsy of related skin growth, first growth | 123 | $14,459 | $94 |
See all 12 services
| Return visit (30+ min) | 253 | $46,197 | $112 |
| Short return visit (20+ min) | 242 | $27,266 | $80 |
| Destruction of precancer skin growth, 1 growth | 247 | $21,175 | $53 |
| Destruction of skin growth, 1-14 growths | 93 | $14,946 | $113 |
| Biopsy of related skin growth, first growth | 123 | $14,459 | $94 |
| Destruction of precancer skin growth, 2-14 growths | 184 | $7,912 | $7 |
| Punch biopsy, first skin growth | 27 | $3,680 | $131 |
| Short return visit | 54 | $2,912 | $50 |
| Long return visit (40+ min) | 12 | $2,843 | $167 |
| Biopsy of related skin growth, each additional growth | 34 | $2,247 | $52 |
| New patient visit (30+ min) | 11 | $1,094 | $99 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 13 | $300 | $15 |
Procedures Medicare counted
| Removal of skin lesions | 723 | More than 90% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 142 | More than 80% of doctors who do this |
Who their Medicare patients are
406 Original Medicare patients in 2024. Average age 77 · Women 63% · Health risk score 0.92. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 56% · Coronary heart disease 22% · Cancer 18% · Atrial fibrillation 18% · Chronic kidney disease 15% · Depression 13% · Diabetes 9% · Heart failure 7% · COPD 7% · Stroke 5% · Dementia 4%.
The office billed $524,120, Medicare allowed $205,248 and paid $151,805; for 2,827 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 406 | 2,827 | 77 | 0.92 | $524,120 | $151,805 |
| 2023 | 384 | 2,874 | 77 | 0.78 | $538,287 | $160,125 |
| 2022 | 369 | 2,839 | 77 | 0.78 | $561,055 | $164,884 |
| 2021 | 369 | 2,824 | 77 | 0.84 | $490,509 | $153,542 |
| 2020 | 353 | 2,350 | 77 | 0.90 | $381,637 | $109,943 |
| 2019 | 442 | 2,824 | 76 | 0.87 | $477,376 | $135,168 |
| 2018 | 402 | 2,967 | 76 | 0.87 | $437,500 | $124,154 |
| 2017 | 361 | 2,904 | 76 | 0.85 | $433,041 | $124,343 |
| 2016 | 351 | 2,267 | 75 | 0.84 | $354,926 | $99,371 |
| 2015 | 289 | 1,710 | 74 | 0.79 | $267,512 | $81,096 |
| 2014 | 272 | 1,619 | 74 | 0.83 | $232,901 | $70,428 |
| 2013 | 226 | 1,153 | 75 | 0.86 | $196,912 | $57,322 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 267 | $51,375 | $109 |
| Short return visit (20+ min) | 218 | $22,314 | $74 |
| Destruction of precancer skin growth, 1 growth | 223 | $18,998 | $50 |
| Destruction of skin growth, 1-14 growths | 118 | $18,145 | $116 |
| Biopsy of related skin growth, first growth | 128 | $15,011 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 181 | $7,532 | $7 |
| Punch biopsy, first skin growth | 31 | $5,277 | $132 |
| Long return visit (40+ min) | 21 | $4,010 | $174 |
| Destruction of precancer skin growth, 15 or more growths | 13 | $3,505 | $175 |
| Biopsy of related skin growth, each additional growth | 47 | $3,372 | $52 |
| Short return visit | 49 | $2,671 | $49 |
2022: 12 services
| Return visit (30+ min) | 245 | $48,590 | $108 |
| Short return visit (20+ min) | 211 | $23,466 | $75 |
| Destruction of precancer skin growth, 1 growth | 218 | $18,530 | $51 |
| Destruction of skin growth, 1-14 growths | 96 | $14,567 | $110 |
| Biopsy of related skin growth, first growth | 125 | $14,356 | $91 |
| Destruction of precancer skin growth, 2-14 growths | 169 | $7,696 | $7 |
| Punch biopsy, first skin growth | 28 | $4,398 | $133 |
| Biopsy of related skin growth, each additional growth | 40 | $3,397 | $52 |
| Destruction of precancer skin growth, 15 or more growths | 14 | $3,387 | $161 |
| Long return visit (40+ min) | 16 | $2,920 | $162 |
| Short return visit | 45 | $2,206 | $43 |
| New patient visit (30+ min) | 12 | $757 | $63 |
2021: 10 services
| Return visit (30+ min) | 258 | $50,974 | $111 |
| Short return visit (20+ min) | 211 | $22,212 | $79 |
| Destruction of precancer skin growth, 1 growth | 216 | $19,748 | $53 |
| Biopsy of related skin growth, first growth | 107 | $12,923 | $103 |
| Destruction of skin growth, 1-14 growths | 90 | $12,620 | $117 |
| Destruction of precancer skin growth, 2-14 growths | 167 | $8,089 | $7 |
| Punch biopsy, first skin growth | 31 | $4,639 | $133 |
| Long return visit (40+ min) | 22 | $4,389 | $169 |
| Biopsy of related skin growth, each additional growth | 33 | $2,462 | $55 |
| Short return visit | 28 | $1,472 | $51 |
2020: 10 services
| Return visit (30+ min) | 249 | $32,903 | $91 |
| Destruction of precancer skin growth, 1 growth | 211 | $16,050 | $50 |
| Short return visit (20+ min) | 171 | $14,970 | $63 |
| Destruction of skin growth, 1-14 growths | 94 | $12,544 | $114 |
| Biopsy of related skin growth, first growth | 90 | $10,087 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 173 | $6,533 | $6 |
| Punch biopsy, first skin growth | 23 | $3,108 | $130 |
| Destruction of precancer skin growth, 15 or more growths | 13 | $2,914 | $162 |
| Biopsy of related skin growth, each additional growth | 22 | $1,845 | $56 |
| Short return visit | 34 | $1,361 | $35 |
2019: 13 services
| Return visit (30+ min) | 258 | $36,240 | $92 |
| Short return visit (20+ min) | 226 | $21,418 | $64 |
| Destruction of precancer skin growth, 1 growth | 234 | $17,572 | $48 |
| Biopsy of related skin growth, first growth | 139 | $15,658 | $91 |
| Destruction of skin growth, 1-14 growths | 98 | $13,437 | $106 |
| Destruction of precancer skin growth, 2-14 growths | 192 | $6,441 | $6 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 15 | $5,001 | None |
| Destruction of precancer skin growth, 15 or more growths | 17 | $3,801 | $152 |
| Short return visit | 68 | $2,966 | $38 |
| Punch biopsy, first skin growth | 19 | $2,602 | $118 |
| Application of light to destroy precancer skin growth | 15 | $2,102 | $131 |
| Biopsy of related skin growth, each additional growth | 30 | $2,017 | $55 |
| New patient visit (30+ min) | 11 | $757 | $69 |
2018: 11 services
| Return visit (30+ min) | 230 | $32,968 | $91 |
| Short return visit (20+ min) | 242 | $20,575 | $59 |
| Destruction of precancer skin growth, 1 growth | 222 | $17,703 | $50 |
| Destruction of skin growth, 1-14 growths | 103 | $14,712 | $107 |
| Biopsy of single growth of skin and/or tissue | 113 | $12,106 | $90 |
| Destruction of precancer skin growth, 2-14 growths | 169 | $5,631 | $5 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 12 | $4,758 | None |
| Destruction of precancer skin growth, 15 or more growths | 15 | $3,211 | $140 |
| Short return visit | 51 | $2,006 | $35 |
| Application of light to destroy precancer skin growth | 12 | $1,703 | $122 |
| Biopsy of each additional growth of skin and/or tissue | 25 | $870 | $30 |
2017: 9 services
| Return visit (30+ min) | 230 | $30,582 | $85 |
| Short return visit (20+ min) | 232 | $22,096 | $62 |
| Destruction of precancer skin growth, 1 growth | 206 | $16,839 | $49 |
| Destruction of skin growth, 1-14 growths | 94 | $14,737 | $106 |
| Biopsy of single growth of skin and/or tissue | 114 | $13,166 | $89 |
| Destruction of precancer skin growth, 2-14 growths | 160 | $5,913 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 22 | $5,372 | $141 |
| Biopsy of each additional growth of skin and/or tissue | 30 | $1,289 | $31 |
| Short return visit | 33 | $1,221 | $36 |
2016: 11 services
| Return visit (30+ min) | 199 | $24,153 | $86 |
| Short return visit (20+ min) | 205 | $17,705 | $61 |
| Biopsy of single growth of skin and/or tissue | 123 | $13,102 | $89 |
| Destruction of precancer skin growth, 1 growth | 193 | $12,792 | $48 |
| Destruction of skin growth, 1-14 growths | 76 | $10,771 | $103 |
| Destruction of precancer skin growth, 2-14 growths | 153 | $4,788 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 22 | $3,993 | $143 |
| New patient visit (30+ min) | 21 | $1,912 | $91 |
| Biopsy of each additional growth of skin and/or tissue | 37 | $1,380 | $30 |
| Short return visit | 30 | $1,345 | $37 |
| New patient visit (15+ min) | 11 | $691 | $63 |
2015: 10 services
| Return visit (30+ min) | 140 | $19,582 | $99 |
| Short return visit (20+ min) | 174 | $16,902 | $62 |
| Destruction of precancer skin growth, 1 growth | 140 | $11,017 | $52 |
| Biopsy of single growth of skin and/or tissue | 91 | $10,584 | $99 |
| Destruction of skin growth, 1-14 growths | 56 | $8,548 | $114 |
| Destruction of precancer skin growth, 2-14 growths | 103 | $3,672 | $6 |
| New patient visit (30+ min) | 19 | $1,577 | $83 |
| Short return visit | 38 | $1,407 | $36 |
| Biopsy of each additional growth of skin and/or tissue | 27 | $960 | $32 |
| New patient visit (15+ min) | 11 | $818 | $74 |
2014: 11 services
| Short return visit (20+ min) | 192 | $17,783 | $58 |
| Destruction of precancer skin growth, 1 growth | 124 | $10,736 | $57 |
| Biopsy of single growth of skin and/or tissue | 83 | $9,317 | $90 |
| Return visit (30+ min) | 53 | $7,819 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 96 | $5,962 | $10 |
| Destruction of skin growth, 1-14 growths | 50 | $5,882 | $98 |
| Short return visit | 62 | $2,641 | $36 |
| Application of ultraviolet light to skin | 13 | $2,273 | $20 |
| New patient visit (30+ min) | 20 | $1,828 | $91 |
| New patient visit (15+ min) | 14 | $916 | $65 |
| Biopsy of each additional growth of skin and/or tissue | 24 | $812 | $30 |
2013: 11 services
| Short return visit (20+ min) | 154 | $13,854 | $59 |
| Biopsy of single growth of skin and/or tissue | 78 | $9,013 | $98 |
| Destruction of precancer skin growth, 1 growth | 108 | $9,009 | $62 |
| Return visit (30+ min) | 51 | $8,237 | $96 |
| Destruction of skin growth, 1-14 growths | 33 | $4,731 | $110 |
| Destruction of precancer skin growth, 15 or more growths | 11 | $2,415 | $161 |
| Destruction of precancer skin growth, 2-14 growths | 81 | $2,359 | $6 |
| Short return visit | 43 | $2,180 | $40 |
| New patient visit (30+ min) | 20 | $1,256 | $63 |
| New patient visit (15+ min) | 14 | $796 | $57 |
| Biopsy of each additional growth of skin and/or tissue | 20 | $730 | $30 |
Drugs they prescribed that Part D paid
$480,235
Pharmacies billed $480,235 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 631) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
566 generic and 65 brand-name prescriptions · $480,235 in drug cost · 15 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Skyrizi | 12 | $248,336 | $20,695 |
| Dupixent | 22 | $114,558 | $5,207 |
| Ciclopirox | 67 | $1,800 | $27 |
| Clobetasol Propionate | 26 | $1,476 | $57 |
| Fluorouracil | 18 | $1,436 | $80 |
See all 17 drugs
| Skyrizi | 12 | $248,336 | $20,695 |
| Dupixent | 22 | $114,558 | $5,207 |
| Ciclopirox | 67 | $1,800 | $27 |
| Clobetasol Propionate | 26 | $1,476 | $57 |
| Fluorouracil | 18 | $1,436 | $80 |
| Fluocinonide | 32 | $1,263 | $39 |
| Triamcinolone Acetonide | 65 | $787 | $12 |
| Ketoconazole | 44 | $781 | $18 |
| Alclometasone Dipropionate | 16 | $764 | $48 |
| Ciclopirox | 26 | $560 | $22 |
| Doxycycline Hyclate | 18 | $402 | $22 |
| Mometasone Furoate | 18 | $291 | $16 |
| Mupirocin | 31 | $276 | $9 |
| Minoxidil | 16 | $237 | $15 |
| Econazole Nitrate | 12 | $204 | $17 |
| Valacyclovir | 18 | $170 | $9 |
| Hydrocortisone | 12 | $87 | $7 |
Year by year
| 2024 | 631 | 225 | 0% (0) | 10% | $480,235 |
| 2023 | 598 | 215 | 0% (0) | 9% | $406,832 |
| 2022 | 535 | 211 | 0% (0) | 5% | $135,236 |
| 2021 | 564 | 205 | 0% (0) | 6% | $84,902 |
| 2020 | 515 | 184 | 0% (0) | 8% | $73,599 |
| 2019 | 528 | 198 | 0% (0) | 7% | $78,480 |
| 2018 | 438 | 187 | 0% (0) | 16% | $118,134 |
| 2017 | 493 | 202 | None | 10% | $67,127 |
| 2016 | 410 | 150 | 0% (0) | None | $35,255 |
| 2015 | 316 | 130 | 0% (0) | 17% | $36,774 |
| 2014 | 272 | 119 | 0% (0) | None | $26,274 |
| 2013 | 325 | 115 | None | None | $23,523 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Skyrizi | 12 | $241,072 | $20,089 |
| Dupixent | 11 | $48,073 | $4,370 |
| Calcipotriene | 12 | $3,265 | $272 |
| Fluorouracil | 35 | $2,626 | $75 |
| Tacrolimus | 12 | $1,992 | $166 |
| Clobetasol Propionate | 31 | $1,902 | $61 |
| Ciclopirox | 42 | $1,318 | $31 |
| Azelaic Acid | 14 | $1,184 | $85 |
| Fluocinonide | 25 | $1,129 | $45 |
| Triamcinolone Acetonide | 62 | $766 | $12 |
| Alclometasone Dipropionate | 16 | $706 | $44 |
| Doxycycline Hyclate | 21 | $685 | $33 |
| Ketoconazole | 30 | $645 | $22 |
| Mometasone Furoate | 27 | $545 | $20 |
| Ciclopirox | 19 | $483 | $25 |
| Mupirocin | 35 | $382 | $11 |
| Clindamycin Phosphate | 17 | $370 | $22 |
| Minoxidil | 22 | $177 | $8 |
2022: 13 drugs
| Fluorouracil | 36 | $3,259 | $91 |
| Calcipotriene | 17 | $2,544 | $150 |
| Fluocinonide | 36 | $2,030 | $56 |
| Ciclopirox | 47 | $1,820 | $39 |
| Clobetasol Propionate | 32 | $1,790 | $56 |
| Alclometasone Dipropionate | 12 | $692 | $58 |
| Mometasone Furoate | 28 | $685 | $24 |
| Clindamycin Phosphate | 18 | $614 | $34 |
| Triamcinolone Acetonide | 51 | $606 | $12 |
| Ketoconazole | 21 | $466 | $22 |
| Valacyclovir | 15 | $343 | $23 |
| Ciclopirox | 15 | $317 | $21 |
| Mupirocin | 33 | $314 | $10 |
2021: 17 drugs
| Metronidazole | 24 | $3,255 | $136 |
| Clobetasol Propionate | 36 | $2,894 | $80 |
| Fluorouracil | 32 | $2,601 | $81 |
| Fluocinonide | 39 | $2,090 | $54 |
| Ciclopirox | 38 | $1,857 | $49 |
| Calcipotriene | 12 | $1,544 | $129 |
| Fluocinolone Acetonide | 13 | $1,327 | $102 |
| Alclometasone Dipropionate | 16 | $1,002 | $63 |
| Ciclopirox | 19 | $985 | $52 |
| Clindamycin Phosphate | 28 | $834 | $30 |
| Ketoconazole | 38 | $785 | $21 |
| Mometasone Furoate | 32 | $724 | $23 |
| Econazole Nitrate | 16 | $555 | $35 |
| Triamcinolone Acetonide | 41 | $484 | $12 |
| Valacyclovir | 15 | $280 | $19 |
| Betamethasone Diprop Augmented | 13 | $274 | $21 |
| Mupirocin | 22 | $158 | $7 |
2020: 15 drugs
| Fluorouracil | 27 | $3,720 | $138 |
| Metronidazole | 17 | $3,030 | $178 |
| Calcipotriene | 16 | $2,436 | $152 |
| Ciclopirox | 47 | $2,286 | $49 |
| Fluocinonide | 33 | $2,236 | $68 |
| Clobetasol Propionate | 31 | $2,112 | $68 |
| Alclometasone Dipropionate | 21 | $1,120 | $53 |
| Econazole Nitrate | 17 | $833 | $49 |
| Mometasone Furoate | 34 | $677 | $20 |
| Ketoconazole | 37 | $647 | $17 |
| Triamcinolone Acetonide | 45 | $600 | $13 |
| Mupirocin | 25 | $240 | $10 |
| Valacyclovir | 14 | $196 | $14 |
| Gabapentin | 13 | $130 | $10 |
| Hydrocortisone | 14 | $103 | $7 |
2019: 15 drugs
| Clobetasol Propionate | 32 | $4,975 | $155 |
| Calcipotriene | 16 | $3,008 | $188 |
| Fluocinonide | 39 | $2,609 | $67 |
| Fluorouracil | 20 | $2,052 | $103 |
| Ciclopirox | 42 | $2,006 | $48 |
| Ketoconazole | 44 | $1,078 | $25 |
| Econazole Nitrate | 15 | $958 | $64 |
| Alclometasone Dipropionate | 18 | $933 | $52 |
| Triamcinolone Acetonide | 60 | $652 | $11 |
| Mometasone Furoate | 22 | $646 | $29 |
| Clindamycin Phosphate | 14 | $566 | $40 |
| Nystatin | 12 | $298 | $25 |
| Valacyclovir | 19 | $259 | $14 |
| Mupirocin | 12 | $148 | $12 |
| Hydrocortisone | 18 | $118 | $7 |
2018: 11 drugs
| Humira | 13 | $64,192 | $4,938 |
| Clobetasol Propionate | 22 | $2,651 | $121 |
| Ciclopirox | 44 | $2,394 | $54 |
| Fluorouracil | 16 | $1,747 | $109 |
| Fluocinonide | 29 | $1,747 | $60 |
| Triamcinolone Acetonide | 61 | $896 | $15 |
| Clindamycin Phosphate | 19 | $857 | $45 |
| Alclometasone Dipropionate | 11 | $793 | $72 |
| Betamethasone Diprop Augmented | 12 | $720 | $60 |
| Mometasone Furoate | 23 | $586 | $25 |
| Ketoconazole | 30 | $456 | $15 |
2017: 13 drugs
| Clobetasol Propionate | 48 | $6,812 | $142 |
| Metronidazole | 15 | $3,308 | $221 |
| Fluocinonide | 40 | $3,001 | $75 |
| Alclometasone Dipropionate | 19 | $1,569 | $83 |
| Fluorouracil | 11 | $1,393 | $127 |
| Ciclopirox | 34 | $1,360 | $40 |
| Betamethasone Dipropionate | 14 | $1,335 | $95 |
| Triamcinolone Acetonide | 67 | $956 | $14 |
| Clindamycin Phosphate | 14 | $707 | $51 |
| Mometasone Furoate | 28 | $589 | $21 |
| Ketoconazole | 19 | $401 | $21 |
| Prednisone | 24 | $178 | $7 |
| Gabapentin | 12 | $73 | $6 |
2016: 9 drugs
| Clobetasol Propionate | 49 | $7,775 | $159 |
| Fluocinonide | 56 | $3,764 | $67 |
| Ciclopirox | 33 | $1,582 | $48 |
| Fluorouracil | 11 | $1,162 | $106 |
| Triamcinolone Acetonide | 48 | $986 | $21 |
| Clindamycin Phosphate | 12 | $631 | $53 |
| Mometasone Furoate | 13 | $368 | $28 |
| Mupirocin | 20 | $299 | $15 |
| Gabapentin | 13 | $236 | $18 |
2015: 7 drugs
| Clobetasol Propionate | 43 | $14,259 | $332 |
| Fluocinonide | 16 | $1,526 | $95 |
| Ciclopirox | 24 | $1,161 | $48 |
| Triamcinolone Acetonide | 39 | $664 | $17 |
| Gabapentin | 19 | $473 | $25 |
| Hydroxychloroquine Sulfate | 12 | $442 | $37 |
| Mupirocin | 12 | $135 | $11 |
2014: 8 drugs
| Clobetasol Propionate | 28 | $3,596 | $128 |
| Desonide | 12 | $2,365 | $197 |
| Fluocinonide | 26 | $1,558 | $60 |
| Tretinoin | 11 | $1,142 | $104 |
| Ciclopirox | 16 | $708 | $44 |
| Triamcinolone Acetonide | 28 | $675 | $24 |
| Nystatin | 18 | $636 | $35 |
| Mupirocin | 16 | $157 | $10 |
2013: 9 drugs
| Desonide | 24 | $3,373 | $141 |
| Clobetasol Propionate | 28 | $1,625 | $58 |
| Fluocinonide | 35 | $1,350 | $39 |
| Nystatin | 30 | $1,083 | $36 |
| Triamcinolone Acetonide | 32 | $993 | $31 |
| Ciclopirox | 13 | $681 | $52 |
| Mupirocin | 20 | $331 | $17 |
| Cephalexin | 11 | $123 | $11 |
| Prednisone | 12 | $76 | $6 |
Money from drug and device companies
$705 in 2025
| 2025 | 8 | 23 | None | $705 |
| 2024 | 9 | 10 | None | $394 |
| 2023 | 2 | 2 | None | $35 |
| 2020 | 4 | 4 | None | $79 |
| 2019 | 4 | 5 | None | $93 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Regeneron Healthcare Solutions | Dupixent | $233 | 6 payments
|
| Sun Pharmaceutical Industries | Ilumya | $146 | 3 payments
|
| Arcutis Biotherapeutics | Zoryve | $87 | 4 payments
|
| Organon | Vtama | $64 | 3 payments
|
| Incyte | Opzelura | $61 | 2 payments
|
| Lilly USA | Ebglyss | $54 | 2 payments
|
See all 23 published payments
| Amgen | Meals · 2025-12-10 | Otezla | $22 |
| Organon | Meals · 2025-12-05 | Vtama | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-12-04 | Dupixent | $17 |
| Regeneron Healthcare Solutions | Education · 2025-12-04 | Dupixent | $81 |
| Amgen | Meals · 2025-11-21 | Otezla | $20 |
| Sun Pharmaceutical Industries | Meals · 2025-11-17 | Winlevi | $14 |
| Sun Pharmaceutical Industries | Education · 2025-11-13 | None | $100 |
| Incyte | Meals · 2025-10-28 | Opzelura | $39 |
| Sun Pharmaceutical Industries | Meals · 2025-10-21 | Ilumya | $32 |
| Regeneron Healthcare Solutions | Meals · 2025-10-14 | Dupixent | $14 |
| Incyte | Meals · 2025-10-08 | Opzelura | $22 |
| Lilly USA | Meals · 2025-09-30 | Taltz | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-09-23 | Dupixent | $18 |
| Organon | Meals · 2025-09-16 | Vtama | $26 |
| Galderma Laboratories L.P. | Meals · 2025-08-21 | Nemluvio | $19 |
| Lilly USA | Meals · 2025-08-05 | Ebglyss | $27 |
| Arcutis Biotherapeutics | Meals · 2025-05-29 | Zoryve | $18 |
| Arcutis Biotherapeutics | Meals · 2025-05-09 | Zoryve | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-04-29 | Dupixent | $18 |
| Arcutis Biotherapeutics | Meals · 2025-03-25 | Zoryve | $26 |
| Regeneron Healthcare Solutions | Education · 2025-01-31 | Dupixent | $85 |
| Organon | Meals · 2025-01-28 | Vtama | $29 |
| Arcutis Biotherapeutics | Meals · 2025-01-24 | Zoryve | $27 |
See earlier years (2024, 2023, 2020, 2019)
2024: $394
| Ucb | Bimzelx | $167 | 1 payment
|
| Incyte | Opzelura | $47 | 2 payments
|
| Abbvie | Skyrizi | $35 | 1 payment
|
| Amgen | Otezla | $31 | 1 payment
|
| Galderma Laboratories L.P. | None | $28 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $28 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $21 | 1 payment
|
| Pfizer | Eucrisa | $20 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $19 | 1 payment
|
2023: $35
| Lilly USA | None | $19 | 1 payment
|
| Pfizer | Cibinqo | $15 | 1 payment
|
2020: $79
| AbbVie | Skyrizi | $22 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $21 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $20 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $15 | 1 payment
|
2019: $93
| Regeneron Healthcare Solutions | Dupixent | $33 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $23 | 1 payment
|
| AbbVie | Humira | $19 | 1 payment
|
| Lilly USA | Taltz | $18 | 1 payment
|
Professional record
- NPI
- 1871541565
- Licence
- CA A74577California A74577: Current · expires 2027-03-31
- Trained
- University of California, Davis School of Medicine, 1999
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-05-04
- NPI last updated
- 2011-11-10
This is when the NPI record was last certified, not a medical board exam.